McIlrath & Eck’s LeonaBio Inc LONA Stock Holding History

McIlrath & Eck’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$843	Hold	82	–	–	﹤0.01%	1498
2025 Q4	$621	Hold	82	–	–	﹤0.01%	944
2025 Q3	$339	Sell	82 -1	-1%	-$4	﹤0.01%	914
2025 Q2	$249	Hold	83	–	–	﹤0.01%	912
2025 Q1	$235	Hold	83	–	–	﹤0.01%	906
2024 Q4	$484	Hold	83	–	–	﹤0.01%	938
2024 Q3	$368	Hold	83	–	–	﹤0.01%	941
2024 Q2	$2.19K	Hold	83	–	–	﹤0.01%	818
2024 Q1	$2.26K	Hold	83	–	–	﹤0.01%	812
2023 Q4	$2K	Hold	83	–	–	﹤0.01%	804
2023 Q3	$1.67K	Hold	83	–	–	﹤0.01%	784
2023 Q2	$2.43K	Hold	83	–	–	﹤0.01%	769
2023 Q1	$2.06K	Hold	83	–	–	﹤0.01%	774
2022 Q4	$2.62K	Hold	83	–	–	﹤0.01%	726
2022 Q3	$2K	Hold	83	–	–	﹤0.01%	741
2022 Q2	$3K	Hold	83	–	–	﹤0.01%	676
2022 Q1	$11K	Hold	83	–	–	﹤0.01%	506
2021 Q4	$11K	Buy	+83	New	+$10.5K	﹤0.01%	518

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

SSC

Spruce Street Capital New York $510M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SFCM

Seven Fleet Capital Management Mountain View, California $606M AUM

McIlrath & Eck's LONA Position: Q1 2026 in Review

McIlrath & Eck held its LeonaBio Inc (LONA) position steady in Q1 2026 at 82 shares worth $843. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

McIlrath & Eck first reported a position in LONA in Q4 2021 and has held it in 18 quarters since. The position peaked at $11K in Q1 2022. 40 funds tracked by Wall St. Rank hold LONA as of Q1 2026.

McIlrath & Eck held 82 shares of LeonaBio Inc worth $843 as of Q1 2026.
McIlrath & Eck left its LeonaBio Inc share count unchanged in Q1 2026.
LeonaBio Inc made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1498 holding.
McIlrath & Eck first reported a position in LeonaBio Inc in Q4 2021 and has held it in 18 quarters since.
McIlrath & Eck's LeonaBio Inc position peaked at $11K in Q1 2022.
40 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.